Number of Current Board & Advisor Roles 1
Number of Founded Organizations 1

William Frazier, Ph.D. co-founded the Company based on research from his laboratory and from the National Institutes of Health. He discovered that CD47 is a receptor for thrombospondin-1 and has been a leader in the field of CD47-mediated signaling pathways, contributing to over 140 publications. Dr. Frazier is a professor of Biochemistry,

Molecular Biophysics, and Cell Biology at Washington University School of Medicine.

Number of Current Jobs 1
William A. Frazier is the Co-founder at Arch Oncology.
Number of Current Board & Advisor Roles 1
William A. Frazier is the Operations Advisor at Gale Project Technologies.
There is no recent news or activity for this profile.